AAAAAA

   
Results: 1-8 |
Results: 8
Wild-type p53-function is not required for hyperthermia-enhanced cytotoxicity of cisplatin
Authors: Van Bree, C Franken, NAP Snel, FAM Haveman, J Bakker, PJM
Citation: C. Van Bree et al., Wild-type p53-function is not required for hyperthermia-enhanced cytotoxicity of cisplatin, INT J HYPER, 17(4), 2001, pp. 337-346
High concentration of daunorubicin and daunorubicinol in human malignant astrocytomas after systemic administration of liposomal daunorubicin
Authors: Albrecht, KW Hamer, PCD Leenstra, S Bakker, PJM Beijnen, JH Troost, D Kaaijk, P Bosch, AD
Citation: Kw. Albrecht et al., High concentration of daunorubicin and daunorubicinol in human malignant astrocytomas after systemic administration of liposomal daunorubicin, J NEURO-ONC, 53(3), 2001, pp. 267-271
The effect of p53-function on the sensitivity to paclitaxel with or without hyperthermia in human colorectal carcinoma cells
Authors: Van Bree, C Savonije, JH Franken, NAP Haveman, J Bakker, PJM
Citation: C. Van Bree et al., The effect of p53-function on the sensitivity to paclitaxel with or without hyperthermia in human colorectal carcinoma cells, INT J ONCOL, 16(4), 2000, pp. 739-744
Long term survivors of childhood brain cancer have an increased risk for cardiovascular disease
Authors: Heikens, J Ubbink, MC van der Pal, HPJ Bakker, PJM Fliers, E Smilde, TJ Kastelein, JJP Trip, MD
Citation: J. Heikens et al., Long term survivors of childhood brain cancer have an increased risk for cardiovascular disease, CANCER, 88(9), 2000, pp. 2116-2121
A multi-center prospective phase II study of high-dose chemotherapy in germ-cell cancer patients relapsing from complete remission
Authors: Rodenhuis, S de Wit, R de Mulder, PHM Keizer, HJ Sleijfer, DT Lalisang, RI Bakker, PJM Mandjes, I Kooi, M de Vries, EGE
Citation: S. Rodenhuis et al., A multi-center prospective phase II study of high-dose chemotherapy in germ-cell cancer patients relapsing from complete remission, ANN ONCOL, 10(12), 1999, pp. 1467-1473
Surgery, radiotherapy, and chemotherapy for esophageal cancer
Authors: Van Lanschot, JJB Ceha, HM Bakker, PJM
Citation: Jjb. Van Lanschot et al., Surgery, radiotherapy, and chemotherapy for esophageal cancer, CURR OPIN G, 15(4), 1999, pp. 370-376
Effectiveness of 2 ',2 ' difluorodeoxycytidine (Gemcitabine) combined withhyperthermia in rat R-1 rhabdomyosarcoma in vitro and in vivo
Authors: Van Bree, C Beumer, C Rodermond, HM Haveman, J Bakker, PJM
Citation: C. Van Bree et al., Effectiveness of 2 ',2 ' difluorodeoxycytidine (Gemcitabine) combined withhyperthermia in rat R-1 rhabdomyosarcoma in vitro and in vivo, INT J HYPER, 15(6), 1999, pp. 549-556
Inactivation of p53 and of pRb protects human colorectal carcinoma cells against hyperthermia-induced cytotoxicity and apoptosis
Authors: van Bree, C van der Maat, B Ceha, HM Franken, NAP Haveman, J Bakker, PJM
Citation: C. Van Bree et al., Inactivation of p53 and of pRb protects human colorectal carcinoma cells against hyperthermia-induced cytotoxicity and apoptosis, J CANC RES, 125(10), 1999, pp. 549-555
Risultati: 1-8 |